Too true, friend. And so far Leronlimab, Tocilizumab, and remdesivir are the only front runners that I can see, and potentially in that order. Although Remdesivir and Tocilizumab potentially can shoot for second place... but they both pale in comparison to what Leronlimab can do.
News 
Market Data 
Discover 
